Hypoxic Preconditioning Modulates BDNF and Its Signaling through DNA Methylation to Promote Learning and Memory in Mice

• Published in: ACS chemical neuroscience Vol. 14; no. 12; pp. 2320 - 2332
• Main Authors: Zhang, Shiji, Fu, Weng, Jia, Xiaoe, Bade, Rengui, Liu, Xiaolei, Xie, Yabin, Xie, Wei, Jiang, Shuyuan, Shao, Guo
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 21-06-2023
• Subjects: Animals; Brain-Derived Neurotrophic Factor - metabolism; DNA Methylation; Hippocampus - metabolism; Hypoxia - metabolism; Learning; Mice; Mice, Inbred ICR; Receptor, trkB - metabolism; DNA methylation; DNA methyltransferase; BDNF/TrkB signaling; brain-derived neurotrophic factor; hypoxic preconditioning; learning and memory
• ISSN: 1948-7193; 1948-7193
• DOI: 10.1021/acschemneuro.3c00069

Hypoxic preconditioning (HPC) as an endogenous mechanism can resist hypoxia/ischemia injury and exhibit protective effects on neurological function including learning and memory. Although underlying molecular mechanisms remain unclear, HPC probably regulates the expression of protective molecules by modulating DNA methylation. Brain-derived neurotrophic factor (BDNF) activates its signaling upon binding to the tropomyosin-related kinase B (TrkB) receptor, which is involved in neuronal growth, differentiation, and synaptic plasticity. Therefore, this study focused on the mechanism by which HPC regulates BDNF and BDNF/TrkB signaling through DNA methylation to influence learning and memory. Initially, the HPC model was established by hypoxia stimulations on ICR mice. We found that HPC downregulated the expression of DNA methyltransferase (DNMT) 3A and DNMT3B. Then, the upregulation of BDNF expression in HPC mice was generated from a decrease in DNA methylation of the BDNF gene promoter detected by pyrophosphate sequencing. Subsequently, upregulation of BDNF activated BDNF/TrkB signaling and ultimately improved learning and spatial memory in HPC mice. Moreover, after mice were intracerebroventricularly injected with the DNMT inhibitor, the restraint of DNA methylation accompanied by an increase of BDNF and BDNF/TrkB signaling was also discovered. Finally, we observed that the inhibitor of BDNF/TrkB signaling prevented HPC from ameliorating learning and memory in mice. However, the DNMT inhibitor promoted spatial cognition in mice. Thus, we suggest that HPC may upregulate BDNF by inhibiting DNMTs and decreasing DNA methylation of the BDNF gene and then activate BDNF/TrkB signaling to improve learning and memory in mice. This may provide theoretical guidance for the clinical treatment of cognitive dysfunction caused by ischemia/hypoxia disease.